Myco-pharmacological investigations of bioactive metabolites and medicinal properties of mushrooms play an important role in the development of new biotech products and biopharmaceuticals. Concerning physiological activities and medicinal properties, Coprinoid mushrooms are poorly studied and not at all exploited. Th e majority of these organisms are fi micolous. However, many of them have also been found on trees and decaying wood (NavarroGonzález et al., in preparation) . Based on molecular data, the traditional genus Coprinus Pers. has now been divided into four clades: Coprinus, Coprinopsis, Coprinellus, and Parasola (Redhead et al., 2001) . For simplicity, we use the traditional nomenclature.
Important in view of biological safety, Coprini are generally nonpathogenic to humans or animals. Less than 10 cases of opportunistic mycoses by Coprini have been recorded worldwide. About 30 years ago, mycelia were isolated from two hearts of immunosuppressed patients who had undergone heart surgery and, in more recent times, from the lungs of three patients suff ering from leukemia, known as non-Hodgkin's lymphoma, who received intensive cytotoxic treatment. Recently, a strain has also been isolated from human skin lesions (Kües et al., 2003) . Coprinus comatus (O.F.Müll.) S.F.Gray may aggravate eczematous skin lesions and induce delayed-type allergic reactions by spores in individuals with atopic dermatitis. Intense eff orts have been invested to identify clinically relevant allergens. C. comatus rCop c1, a protein of no known function, was able to induce strong specifi c skin reactions in sensitized individuals (Helbling et al., 2002) .
Mushrooms are very good dietary sources of food (referred to as neutraceuticals) contributing to the general well-being. Th ey are rich in proteins, carbohydrates, fi bers, unsaturated fatty acids, vitamins, and minerals, but low in calories (Kües et al., 2003) . While most Coprinus species are inherently not eaten for practical reasons (fast autodigestion of the fruiting bodies), a few species are regularly consumed by humans, and a toxic-lethal species does not appear to exist. However, among the chosen edible species is C. atramentarius (Bull.) Fr., users of which, in combination with alcohol consumption, describe hot fl ushes of the face and neck, a metallic taste, tingling sensation in the limbs, nausea, and vomiting. Occasionally, these symptoms occur also upon ingesting C. africanus Pegler (in Nigeria called "Ajeimutin" for aje = eat + imu = without drinking + otin = alcohol), C. insignis Peck, C. quadrifi dus Peck, and C. variegatus Peck together with alcohol. Th e unpleasant eff ects are mediated by the rather unique toxin Coprine, an atypical amino acid that inhibits acetaldehyde dehydrogenase and thus blocks the metabolism of ethanol. Remission takes place within a few hours. Th is Coprinus syndrome is analogous to the non-lethal symptoms of Antabuse (disulfi ram) that is applied in the treatment of alcoholism without resulting in the negative mutagenic and gonadotoxic side eff ects of Coprine.
Many Coprini appear to be useful natural sources Aqueous extracts from C. comatus and C. atramentarius inhibited vegetative growth and sporulation of Penicillium expansum and phytopathogens, too. A strong antiviral activity was described in C. micaceus. Antibacterial and antifungal activity in mutants of C. cinereus (Schaeff .) S.F.Gray was due to sesquiterpenoid quinones (lagopodins, hydroxylagopodins) found in mycelial extracts and supernatants of fungal cultures. Illudins are the best studied sesquiterpenes having antibacterial and, most importantly, also cytotoxic eff ects against tumor cells. C. atramentarius was shown to produce illudin C derivates, C-2 and C-3, and C. episcopalis P.D. Orton to produce the three novel illudins I, I-2, and J2. C. gonophylus Quél. produced only illudinic acid. Antitumor activity was detected in C. atramentarius and C. comatus. Polysaccharides isolated from C. comatus inhibited tumor growth. 1-aminocyclopropane-1-carboxylic acid is a component of the species aff ecting reproductivity of male mice of the SHN line (characterized by a high risk of spontaneous mammary tumorigenesis). Furthermore, culture broth extracts of C. disseminatus (Pers.) S.F.Gray inhibited proliferation and induced apoptosis in certain human cervical carcinoma cell lines. An antibiotic from a culture broth of C. radiatus showed in vivo an anti-leukemia eff ect.
Many Coprini are characterized by strong proteolytic activity (fi brinolytic, thrombolytic, caseinolytic) that can be of medicinal interest. Galectins, a specifi c class of lectins detected in fruiting bodies of C. cinereus (Schaeff .) S.F.Gray, might be tested for therapies of muscular dystrophy or T-cell-mediated liver disorders where positive aff ects by mammalian galectin-1 were reported. A mild hypoglycemic eff ect (reducing plasma glucose concentration) by C. comatus described in mice might be exploited through a dietary adjunct (nutriceutical) in treatment of diabetes. Fınally, hydrophobins, small nontoxic hydrophobic surface-active fungal proteins found also in C. cinereus, are most interesting candidates for various medical and pharmacological applications such as increasing biocompatibility of medical implants, immobilization of antibodies in a biosensor, stabilizing oil vesicles for drug delivery, and patterning molecules at the cell surface. In conclusion, Coprini are producers of various types of biologically active molecules and proteins whose further investigation will assist in obtaining new preventive and curative mushroom-based biopharmaceuticals and food additives. A more detailed review with appropriate references will be given elsewhere.
In our own screening program of Coprini, antifungal activity of C. cinereus, C. comatus, and C. atramentarius was observed in Aspergillus niger, A. versicolor, A. fl avus, Penicillium simplicissimum, P. jensenii, P. chrysogenum, Fusarium sambucinum, Cladosporium atroseptum, Stemphylium botryosum , and Hormiscium sp. C. comatus had the highest activity, followed by C. cinereus and then C. atramen tarius, while from the tested fungi, Aspergillus species acted in the most antagonistic way against mushroom cultures. C. disseminatus (Pers.) S.F.Gray and C. micaceus prevented or markedly suppressed the growth of numerous fungi potentially pathogenic for humans and animals (Aspergillus candidus, A. fl avus, A. wentii, Fusarium tricinctum, Stachybotris chartarum, Acre monium alternatum, Chrysosporium keratinophillum, Penicillium aurantiogriseum, P. griseo fulvum, Altern aria alternata, Cladosporium cladosporoides, and Verticillium lecanii ). Only A. fl avus exhibited a relatively high resistance against C. micaceus. Strong antiprotozoal activity against Paramecium caudatum was present in culture liquids of C. comatus, whereas diff erent concentrations of mycelial extracts showed up to a 2.8-fold mitogenic stimulation towards the
